Clinical

01

Pre-clinical (R&D)

Done

02

Feasibility Study

Actively recruiting

03

Clinical Trial

Done

04

Limited Availability

Done

05

General Availability

Done

01

Pre-clinical (R&D)

Done

02

Feasibility Study

Actively recruiting

03

Clinical Trial

Done

04

Limited Availability

Done

05

General Availability

Done

The brain is the most critical organ, controlling all other bodily functions, yet it is one of the least understood and most complex parts of the body.

Gaining a better understanding of the brain unlocks the opportunity for significant medical advances, only some of which we currently understand. CoMind’s technology aims to improve the lives of patients, and has the potential to unlock new insights into understanding the brain and its functions. This has the potential to change the way we approach brain health and technology, and ultimately, make a lasting impact on society.

CoMind's Clinical Advisory Board

The Clinical Advisory Board is composed of distinguished experts in the fields of neurology, neurosurgery, anesthesiology and critical care. Bringing decades of experience and a wealth of knowledge, these leaders provide independent broad-scope scientific and clinical guidance for the development and clinical application work being undertaken at CoMind.

Prof. John Gallagher

Clinical Advisory Board Member

Prof. Andrew Kofke

Clinical Advisory Board Member

Mary Kay Bader

Clinical Advisory Board Member

Dr. Howard Riina, MD

Clinical Advisory Board Member

Dr. Ramani Balu, MD

Clinical Advisory Board Member

Prof. Chris A Troianos

Clinical Advisory Board Member

© 2025 - CoMind Technologies Limited

© 2025 - CoMind Technologies Limited

© 2025 - CoMind Technologies Limited